Cyclobarbital
Systematic (IUPAC) name | |
---|---|
5-(1-cyclohexenyl)-5-ethyl-1,3-diazinane-2,4,6-trione | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status |
|
Routes of administration | Oral |
Pharmacokinetic data | |
Metabolism | Hepatic |
Excretion | Renal |
Identifiers | |
CAS Number | 143-76-0 |
ATC code | N05CA10 |
PubChem | CID 5838 |
ChemSpider | 5632 |
UNII | 0M8A98AD9H |
KEGG | D07323 |
ChEMBL | CHEMBL268164 |
Chemical data | |
Formula | C12H16N2O3 |
Molar mass | 236.267 g/mol |
| |
| |
(what is this?) (verify) |
Cyclobarbital, also known as cyclobarbitol or cyclobarbitone, is a drug which is a barbiturate derivative.[1] It is primarily available in fixed-dose combination with diazepam under the brand name Reladorm (100 mg cyclobarbital + 10 mg diazepam) and is used to treat insomnia in Russia.
References
|
This article is issued from Wikipedia - version of the Monday, October 12, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.